Opposing actions of chronic Delta9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation
about
Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findingsDelta9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampusMolecular model of cannabis sensitivity in developing neuronal circuitsReduced expression of glutamate receptors and phosphorylation of CREB are responsible for in vivo Delta9-THC exposure-impaired hippocampal synaptic plasticityGene-environment interplay between cannabis and psychosisGlutamatergic substrates of drug addiction and alcoholismMismatch Negativity and P50 Sensory Gating in Abstinent Former Cannabis Users.Control of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptorsNicotine-induced anxiety-like behavior in a rat model of the novelty-seeking phenotype is associated with long-lasting neuropeptidergic and neuroplastic adaptations in the amygdala: effects of the cannabinoid receptor 1 antagonist AM251Augmented Inhibition from Cannabinoid-Sensitive Interneurons Diminishes CA1 Output after Traumatic Brain Injury.Hippocampal CB(1) receptors mediate the memory impairing effects of Delta(9)-tetrahydrocannabinol.Are CB(1) Receptor Antagonists Nootropic or Cognitive Impairing Agents?Recruitment of hippocampal neurons to encode behavioral events in the rat: alterations in cognitive demand and cannabinoid exposure.Differential effects of TRPV1 receptor ligands against nicotine-induced depression-like behaviors.Cognitive function as an emerging treatment target for marijuana addictionΔ9-THC-caused synaptic and memory impairments are mediated through COX-2 signalingCell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling.Disposition of cannabichromene, cannabidiol, and Δ⁹-tetrahydrocannabinol and its metabolites in mouse brain following marijuana inhalation determined by high-performance liquid chromatography-tandem mass spectrometry.Prolonged cannabinoid exposure alters GABA(A) receptor mediated synaptic function in cultured hippocampal neuronsThe role of cannabinoids in modulating emotional and non-emotional memory processes in the hippocampus.Endocannabinoid tone versus constitutive activity of cannabinoid receptors.Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity.Alterations of endocannabinoid signaling, synaptic plasticity, learning, and memory in monoacylglycerol lipase knock-out miceCannabis, Cigarettes, and Their Co-Occurring Use: Disentangling Differences in Gray Matter Volume.γ-Amino butyric acid and glutamate abnormalities in adolescent chronic marijuana smokers.Cannabis use in early adolescence: Evidence of amygdala hypersensitivity to signals of threatDissociation of the pharmacological effects of THC by mTOR blockade.Synaptic targets of Δ9-tetrahydrocannabinol in the central nervous system.The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction.Modulation of excitatory synaptic transmission by Delta 9-tetrahydrocannabinol switches from agonist to antagonist depending on firing rateThe Influence of the CB1 Receptor Ligands on the Schizophrenia-Like Effects in Mice Induced by MK-801The effect of cannabis use on memory function: an update.Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids.Effects of drugs of abuse on hippocampal plasticity and hippocampus-dependent learning and memory: contributions to development and maintenance of addiction.Nigrostriatal denervation changes the effect of cannabinoids on subthalamic neuronal activity in rats.A cannabinoid CB(1) receptor antagonist ameliorates impairment of recognition memory on withdrawal from MDMA (Ecstasy).Scientific Opinion on the risks for human health related to the presence of tetrahydrocannabinol (THC) in milk and other food of animal originThe CB(1) receptor antagonist, AM281, improves recognition loss induced by naloxone in morphine withdrawal mice.Disruption of hippocampal synaptic transmission and long-term potentiation by psychoactive synthetic cannabinoid 'Spice' compounds: comparison with Δ9 -tetrahydrocannabinol.Chronic activation of CB2 cannabinoid receptors in the hippocampus increases excitatory synaptic transmission.
P2860
Q21559698-97C07621-A684-43D2-A07B-80A0EC33838DQ24597687-289F1436-9447-468A-9803-D79970D0C5EDQ24613715-2E504BDD-F6EA-4400-9B52-4D8745EE137DQ24642505-5CCDF8F5-5D3B-4A2E-B2E4-302C7DC5266BQ24643510-5CCB5AD6-1E81-433C-AE73-F4088A5F5B49Q24648924-87F7AD54-9B1B-42B4-912E-A145CE633E7AQ27312326-C9B66820-2D62-4A70-BBC2-FAAE2C0467AAQ28270337-65E0AC2D-E199-4B47-A35B-847A14330B12Q28564481-0925A469-4ABE-406F-9EAC-3914112CBE9DQ30609922-9147DA0E-09FA-47D6-8AFF-2AAE80961876Q33655408-347F59DC-24A4-4FA5-8A65-5BE2D7A2B282Q33901801-4F2B22E3-685B-4942-853B-F44AD0594572Q33937200-EFD5C142-98B4-46EF-A40D-A18B516ADE96Q33964434-7B072378-05E8-40E3-BE38-03B35A14A9C0Q34018386-34DA38B9-BC71-4D58-8100-2643AE133574Q34387254-A6BA94C3-8BC0-4424-9D73-4054C2499127Q34452582-7C624BDD-5538-48FF-86C5-349887B8FA1EQ34505221-52794392-DACB-4399-95B0-E653AE26B961Q35000519-8EDEBED0-EF06-4BAB-B287-71F917961620Q35072848-E26AC176-7193-4DC5-85CA-8BC94B618B9EQ35193265-2B50CED0-3CB1-490E-9835-95D09C5BCDE8Q35896661-287E6090-0C7A-4641-89E6-73FEA608A8C5Q36020820-B2F7A653-5C46-4307-A479-7A40A0B206B7Q36287890-7A7381C8-2205-4054-8202-169B2BFC0B46Q36295861-4F7619FF-C336-4CB0-AC79-E527C4EB7FDEQ36710044-D70B0215-C865-42DD-9DFE-851A07E7CF3DQ36850581-1F146A6A-420B-4D6C-A993-3EBE1D392406Q37040227-BFA9A0A1-0381-4A14-AC5D-FC6AB454F0AEQ37142233-C08702ED-EC5D-47E0-A9C9-AAEC4005D292Q37199151-9D75A344-30EF-4E97-8F01-2D725C58FC88Q37306525-25346ADF-6DED-44D1-8ED8-AAD01AF26BDDQ37597512-27936148-A624-4E4B-8A42-334CDAA1FCB9Q38056395-43C536BD-A8EA-4891-BF4D-6DE81B4A1AF1Q38820699-975E260D-7717-4CC3-9F80-1CAAF7C0AD99Q41809772-522DEB87-F1D1-4F01-90B8-E90A1A98B231Q42148727-51E17CD4-D479-490A-8181-77B883F34DA2Q47157045-171BC54C-0791-4C48-8F3E-8F3617CC1617Q48004497-A7EFE4A6-E196-4B6B-BD8B-26A3D35E5296Q48269342-131AC85B-2DD7-4A7F-9CB3-194E2675C2AEQ48413374-426E1806-2BB8-4F42-ABEA-7DF483E12531
P2860
Opposing actions of chronic Delta9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Opposing actions of chronic De ...... ocampal long-term potentiation
@ast
Opposing actions of chronic De ...... ocampal long-term potentiation
@en
type
label
Opposing actions of chronic De ...... ocampal long-term potentiation
@ast
Opposing actions of chronic De ...... ocampal long-term potentiation
@en
prefLabel
Opposing actions of chronic De ...... ocampal long-term potentiation
@ast
Opposing actions of chronic De ...... ocampal long-term potentiation
@en
P2093
P2860
P356
P1433
P1476
Opposing actions of chronic De ...... ocampal long-term potentiation
@en
P2093
Aron H Lichtman
Ruiqin Yang
P2860
P356
10.1101/LM.439007
P577
2007-01-03T00:00:00Z